Psilocybin therapy for inherited trauma
Treatments studied
Part of Mental health clinical trials.
This trial tests whether psilocybin (a psychedelic substance) combined with therapy can help adult children of genocide survivors who experience symptoms of trauma, depression, or anxiety. The goal is to see if this approach can reduce the emotional impact of intergenerational trauma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are the biological child of at least one parent who directly survived or escaped a genocide.
- You have significant symptoms of intergenerational trauma, like intrusive thoughts, hypervigilance, or avoidance.
- You have been diagnosed with depression, anxiety, or a trauma- or stress-related disorder.
- You are willing to stop taking certain medications (like antidepressants) before the study, with guidance from the study team and your doctor.
- You can travel for in-person visits and are comfortable with sessions being audio and video recorded.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
This trial tests psilocybin (a compound from certain mushrooms) combined with a structured therapy to see if it helps people with depression linked to trauma. It focuses on how the treatment affects the connection between the gut and brain.
This trial tests whether psilocybin, a substance that can help the brain process trauma, combined with therapy can reduce PTSD symptoms in people who have experienced intimate partner violence. You must be at least 6 months past the last incident and not have serious health or mental health issues.
This trial tests a type of therapy that uses psilocybin (a safe, natural substance found in certain mushrooms) to help people with PTSD. It combines talk therapy with the medicine to see if it can reduce trauma symptoms.
This study tests if psilocybin-assisted group therapy can help people with moderate to severe PTSD. It is for veterans, first responders, female survivors of sexual violence, or Indigenous individuals.
This trial tests whether psilocybin, a psychedelic drug given in a supportive therapy setting, can help women heal from post-traumatic stress disorder (PTSD) caused by a sexual assault that happened 6 or more months ago. You'll receive the drug during supervised sessions and attend therapy visits to see if it reduces your PTSD symptoms.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.